Press Coverage

Neurosurgeons identify malign tumors with Cellvizio optical biopsy

11 September 2015

A team of neurosurgeons in Germany has used the Cellvizio optical biopsy system to identify cancerous brain and spinal tumors in real time, suggesting that the technology could be used for immediate diagnosis in future operations to improve surgical outcomes and patient recovery.

Latest News

Mauna Kea Technologies announces Initiation of Coverage by Allinvest Securities 

Mauna Kea Technologies announces Initiation of Coverage by Allinvest Securities 

Mauna Kea Technologies announces its 2026 financial calendar highlighted by its participation in several investor forums

Mauna Kea Technologies announces its 2026 financial calendar highlighted by its participation in several investor forums

Mauna Kea Technologies Reports Strong Q4 2025 Sales Driven by Accelerated Growth in the U.S. 

Mauna Kea Technologies Reports Strong Q4 2025 Sales Driven by Accelerated Growth in the U.S. 

No results found.